FOS and hypertensive disorder: Representative digital images of Fos‐IR expression in the OVLT (Figure 5A), MnPO (Figure 5B), SFO (Figure 5C), AP (Figure 5D), NTS (Figure 5E), and RVLM (Figure 5F) in untreated (Figures 5, 6, 7, 8, 9, 10, 11a), saline‐administered (Figures 5, 6, 7, 8, 9, 10, 11b‐f), HTN‐administered (Figure 5A, B‐h‐l), and PEG‐administered (Figure 5A, B‐m‐q) rats at 0 hr (Figure 5A, B‐b, h, m), 3 hr (Figure 5A, B‐c, i, n), 6 hr (Figure 5A, B‐d, j, o), 12 hr (Figure 5A, B‐e, k, p), and 24 hr (Figure 5A, B‐f, l, q) after treatment are shown.